Abstract
IL10 is an anti-inflammatory cytokine that suppresses colitis and colitis-associated colon cancer, but it has recently been found to be a risk locus associated with ulcerative colitis. The mechanism underlying the contrasting roles of IL10 in inflammation and colon cancer is unknown. We report here that inflammation induces accumulation of CD11b+Gr1+ myeloid-derived suppressor cells that express high level of IL10 in colon tissue. IL10 induces activation of STAT3 that directly binds to the Dnmt1 and Dnmt3b promoters to activate their expression, resulting in DNA hypermethylation at the Irf8 promoter to silence IRF8 expression in colon epithelial cells. Mice with an Irf8 knock out in colonic epithelial cells exhibit a significantly higher inflammation-induced tumor incidence. Our data identify the MDSC-IL10-STAT3-DNMT-IRF8 pathway as a link between chronic inflammation and colon cancer initiation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
